| 001 | 300617 | ||
| 005 | 20250819094929.0 | ||
| 024 | 7 | _ | |a 10.1038/s41596-025-01164-6 |2 doi |
| 024 | 7 | _ | |a pmid:40251421 |2 pmid |
| 024 | 7 | _ | |a 1754-2189 |2 ISSN |
| 024 | 7 | _ | |a 1750-2799 |2 ISSN |
| 024 | 7 | _ | |a altmetric:176239825 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-00831 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Makarem, Ata |b 0 |
| 245 | _ | _ | |a Byproducts in the synthesis of [68Ga]Ga-PSMA-11. |
| 260 | _ | _ | |a Basingstoke |c 2025 |b Nature Publishing Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1755589748_6400 |2 PUB:(DE-HGF) |x Letter |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #LA:W160# / epub / Matters arising |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Han, Jianlin |b 1 |
| 700 | 1 | _ | |a Klika, Karel |0 P:(DE-He78)c53db83479d3d1265967405af71f69bb |b 2 |e Last author |
| 773 | _ | _ | |a 10.1038/s41596-025-01164-6 |0 PERI:(DE-600)2244966-8 |p nn |t Nature protocols |v nn |y 2025 |x 1754-2189 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:300617 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)c53db83479d3d1265967405af71f69bb |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-18 |w ger |
| 915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2024-12-18 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-18 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-18 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT PROTOC : 2022 |d 2024-12-18 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b NAT PROTOC : 2022 |d 2024-12-18 |
| 920 | 2 | _ | |0 I:(DE-He78)W160-20160331 |k W160 |l Molekulare Strukturanalyse |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)W160-20160331 |k W160 |l Molekulare Strukturanalyse |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)W160-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|